NDC 73377-190-01 - Triclabendazole Micronized

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 73377-190
Requested NDC: 73377-190-01
Package NDCs from labels: 73377-190-01
Manufacturer: AX Pharmaceutical Corp | Alivira Animal Health LImited
Effective date: 2022-09-15
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
TRICLABENDAZOLE - AX Pharmaceutical Corp \| Alivira Animal Health LImited	AX Pharmaceutical Corp \| Alivira Animal Health LImited	2022-09-15	BULK INGREDIENT - ANIMAL DRUG

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73377-190-01	Triclabendazole Micronized	500 g in 1 JAR	POWDER	500		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73377-190	TRICLABENDAZOLE MICRONIZED POWDER [AX PHARMACEUTICAL CORP]	1	1 package rows	20220919_2ebc302e-1ffd-4be4-95e6-a341251c9e06.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EGATEN	TRICLABENDAZOLE	Novartis Pharmaceuticals Corporation	5552884e-10ea-450c-9658-d3d4f33c946e	2026-06-04	Warnings, Adverse reactions	Exact identifier unii: 4784C8E03O

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.